Sarcopenia before neoadjuvant treatment of esophagogastric adenocarcinoma is associated with significantly higher mortality rates in the five years after surgery, according to a study by researchers from the United Kingdom.
“Sarcopenia is a very important topic in clinical medicine and oncology because it is recognized as an independent risk factor for bad outcomes,” said Vivek Kaul, MD, the Segal-Watson Professor of Medicine at the University of Rochester Medical Center and Strong